GlassScriptPhysician profile
Aydin H Pooli
NPI 1548558067
$7,263.75
in general payments reported to CMS, 2019-2025
30 companies · $2,811 in 2025
The $2,811 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $129 · 2021: $804 · 2022: $1,265 · 2023: $267 · 2024: $1,280 · 2025: $2,811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,925 · Food and Beverage: $1,745 · Travel and Lodging: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,925.00 |
| Food and Beverage | $1,744.53 |
| Travel and Lodging | $689.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,935.72 | 2024-2025 | |
| Teleflex LLC | $1,156.89 | 2021-2025 | Barrigel, Urolift |
| Procept Biorobotics Corporation | $911.60 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $486.90 | 2020-2023 | |
| Smith+Nephew, INC. | $374.24 | 2021-2024 | Stravix |
| Biotissue Holdings INC. | $343.78 | 2021-2024 | |
| Coloplast Corp | $243.88 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $228.26 | 2019-2022 | |
| Baxter Healthcare | $199.16 | 2023-2025 | Perclot |
| Neotract INC. | $171.39 | 2019 | |
| Boston Scientific Corporation | $168.64 | 2019 | |
| Abbvie INC. | $143.08 | 2019-2024 | |
| Amgen INC. | $124.99 | 2019 | |
| Janssen Biotech, INC. | $118.20 | 2019 | |
| Integra Lifesciences Corporation | $100.30 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $95.94 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $78.35 | 2021 | |
| Blue Earth Diagnostics | $68.83 | 2024-2025 | Posluma |
| Amniox Medical, INC. | $44.32 | 2020 | |
| Astellas Pharma US INC | $40.28 | 2019 | |
| Tolmar, INC. | $38.69 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $32.28 | 2023-2025 | Bard Urinary Drainage Bag |
| Bluewind Medical | $29.32 | 2024 | Revi |
| Dendreon Pharmaceuticals LLC | $28.04 | 2025 | Provenge |
| Olympus America INC. | $21.42 | 2022 | |
| Convatec INC. | $20.76 | 2021 | |
| Myovant Sciences INC. | $20.36 | 2021 | |
| Urogen Pharma, INC. | $19.94 | 2024 | |
| Axonics, INC. | $14.43 | 2023 | Bulkamid, Axonics |
| Intuitive Surgical, INC. | $3.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aydin Pooli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.